Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

AMOEBA Aktie

>AMOEBA Performance
1 Woche: 0%
1 Monat: -19,8%
3 Monate: -0,3%
6 Monate: +9,1%
1 Jahr: +148,8%
laufendes Jahr: +9,1%
>AMOEBA Aktie
Name:  AMOEBA EO -,02
Land:  Frankreich
Sektor:  Chemie
ISIN/ Wkn:  FR0011051598 / A14WL9
Symbol/ Ticker:  A1H (Frankfurt)
Kürzel:  FRA:A1H, ETR:A1H, A1H:GR
Index:  -
Webseite:  http://www.amoeba-biocide..
Marktkapitalisierung:  51.1 Mio. EUR
Umsatz:  0.6016 Mio. EUR
EBITDA:  -5.12 Mio. EUR
Gewinn je Aktie:  -0.13 EUR
Schulden:  12.07 Mio. EUR
Liquide Mittel:  0.45894 Mio. EUR
Umsatz-/ Gewinnwachstum:  -9.4% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / 3.4 / -
Gewinnm./ Eigenkapitalr.:  - / -
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  AMOEBA
Letzte Datenerhebung:  06.07.25
>AMOEBA Eigentümer
Aktien: 51.61 Mio. St.
f.h. Aktien: 49.63 Mio. St.
Insider Eigner: 29.54%
Instit. Eigner: 0.24%
Leerverk. Aktien: -
>AMOEBA Peer Group

 
25.06.25 - 08:48
 AMOEBA : Exemption from the obligation to destroy crops in France obtained by Amoéba (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
17.06.25 - 18:01
 AMOEBA : Amoéba takes another decisive step forward with the final approval of its biocontrol active substance by the European Commission (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
06.06.25 - 22:12
 Texas Woman Dies Of Brain-Eating Amoeba After Using Tap Water For Sinus Rinse (AFX)
 
WASHINGTON (dpa-AFX) - A woman in Texas died from a rare brain infection after using tap water to clean her sinuses, according to a report from the Centers for Disease Control and Prevention (CDC)......
03.06.25 - 17:48
 AMOEBA : Koppert and Amoéba sign major distribution agreement for innovative biofungicide solution (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
22.05.25 - 18:01
 AMOEBA : Amoéba: Ordinary and Extraordinary General Meeting of 26 June 2025 (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
20.05.25 - 19:00
 AMOEBA : Amoéba announces the nomination of Charlotte Franceries, a leading figure in the cosmetics and communications industry, to its Board of Directors (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
12.05.25 - 18:00
 AMOEBA : Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba. (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
06.05.25 - 08:00
 AMOEBA : Amoéba obtains an exceptional exemption in the Netherlands for its biocontrol product AXPERA for large-scale greenhouse trials (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
17.04.25 - 18:00
 AMOEBA : Amoéba announces the publication of its Universal Registration Document 2024 (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
14.04.25 - 08:48
 AMOEBA : Amoéba announces a second initiation of coverage by KBC Securities and confirms its new international dimension (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
20.03.25 - 18:00
 AMOEBA : Amoéba is the French partner in the European SAGROPIA project (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
10.03.25 - 18:00
 AMOEBA : Amoéba confirms the extension of production capacity of its Chassieu site (France) to support its commercial deployment (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
23.01.25 - 18:00
 AMOEBA : Amoéba announces the initiation of coverage of its stock by Euroland Corporate with a target price of EUR 2.40 (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
15.01.25 - 17:48
 AMOEBA : Amoéba announces the publication of the EFSA′s final report confirming its positive and definitive conclusions (Actusnews)
 
Full and original release on www.actusnews.com. Subscribe to this company's information....
06.01.25 - 11:09
 Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program (PR Newswire)
 
SHANGHAI, Jan. 6, 2025 /PRNewswire/ -- Asieris Pharmaceuticals (Stock Code: 688176.SH), a leading global biopharmaceutical company dedicated to advancing innovative therapies for genitourinary tumors and women's health with significant unmet medical needs, announced the signing of an......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!